Clinical Trial Update: PrEPared to Choose (PtC) is an Implementation Study of the Delivery of Cabotegravir Long-acting, an Injectable Pre-exposure Prophylaxis (PrEP) Option for HIV Prevention. Injectable PrEP Will be Offered Alongside Oral and Vaginal Ring PrEP From Within a Real-world Context in Cape Town, South Africa.

View source ↗

Summary

Implementation study in Cape Town evaluates delivering cabotegravir long-acting injectable PrEP alongside oral and vaginal ring PrEP in real-world settings.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• APRETUDE (CABOTEGRAVIR)

Snippet

Sponsor: Desmond Tutu HIV Foundation | Conditions: HIV Infection, Sexual and Reproductive Health | Status: RECRUITING